1. Home
  2. TLSI vs UBFO Comparison

TLSI vs UBFO Comparison

Compare TLSI & UBFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • UBFO
  • Stock Information
  • Founded
  • TLSI 2010
  • UBFO 1987
  • Country
  • TLSI United States
  • UBFO United States
  • Employees
  • TLSI N/A
  • UBFO 114
  • Industry
  • TLSI Medical Specialities
  • UBFO Major Banks
  • Sector
  • TLSI Health Care
  • UBFO Finance
  • Exchange
  • TLSI Nasdaq
  • UBFO Nasdaq
  • Market Cap
  • TLSI 160.4M
  • UBFO 162.0M
  • IPO Year
  • TLSI N/A
  • UBFO N/A
  • Fundamental
  • Price
  • TLSI $5.02
  • UBFO $9.06
  • Analyst Decision
  • TLSI Strong Buy
  • UBFO
  • Analyst Count
  • TLSI 6
  • UBFO 0
  • Target Price
  • TLSI $11.75
  • UBFO N/A
  • AVG Volume (30 Days)
  • TLSI 34.6K
  • UBFO 28.7K
  • Earning Date
  • TLSI 05-23-2025
  • UBFO 04-17-2025
  • Dividend Yield
  • TLSI N/A
  • UBFO 5.30%
  • EPS Growth
  • TLSI N/A
  • UBFO N/A
  • EPS
  • TLSI N/A
  • UBFO 0.77
  • Revenue
  • TLSI $29,431,000.00
  • UBFO $47,362,000.00
  • Revenue This Year
  • TLSI $55.13
  • UBFO N/A
  • Revenue Next Year
  • TLSI $50.71
  • UBFO N/A
  • P/E Ratio
  • TLSI N/A
  • UBFO $11.72
  • Revenue Growth
  • TLSI 58.99
  • UBFO N/A
  • 52 Week Low
  • TLSI $3.50
  • UBFO $7.07
  • 52 Week High
  • TLSI $10.24
  • UBFO $10.49
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 34.87
  • UBFO 56.86
  • Support Level
  • TLSI $4.66
  • UBFO $8.95
  • Resistance Level
  • TLSI $5.40
  • UBFO $9.25
  • Average True Range (ATR)
  • TLSI 0.37
  • UBFO 0.26
  • MACD
  • TLSI -0.06
  • UBFO 0.08
  • Stochastic Oscillator
  • TLSI 29.51
  • UBFO 64.54

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About UBFO United Security Bancshares

United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.

Share on Social Networks: